| Gulf South Foot & Ankle, Llc | |
|
2520 Harvard Ave, Suite 2b, Metairie, LA 70001-1118 | |
| (504) 454-3004 | |
| (504) 454-3075 |
| Full Name | Gulf South Foot & Ankle, Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 2520 Harvard Ave, Metairie, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649563008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Provider Name | Maria D Markiewicz |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1144293853 PECOS PAC ID: 8325076839 Enrollment ID: I20050727000130 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Provider Name | Robert J Lagman |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1790720514 PECOS PAC ID: 0547353336 Enrollment ID: I20070911000014 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Provider Name | Leon T Watkins |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1548290133 PECOS PAC ID: 5890851299 Enrollment ID: I20090612000399 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Provider Name | Anthony G. Perry |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1710933064 PECOS PAC ID: 2365585122 Enrollment ID: I20100203000061 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Provider Name | Amanda L Mudek |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1134494834 PECOS PAC ID: 5294016242 Enrollment ID: I20220803000037 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Provider Name | Beau Douglas Willis |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1396164679 PECOS PAC ID: 6406145937 Enrollment ID: I20220928000549 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Provider Name | Chelsea Elizabeth Thayer |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1558947580 PECOS PAC ID: 1951787977 Enrollment ID: I20220928003284 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gulf South Foot & Ankle, Llc 2520 Harvard Ave, Suite 2b, Metairie, LA 70001-1118 Ph: (504) 454-3004 | Gulf South Foot & Ankle, Llc 2520 Harvard Ave, Suite 2b, Metairie, LA 70001-1118 Ph: (504) 454-3004 |
News Archive
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
Findings from three large, randomized Phase III studies demonstrate the superiority of Tasigna (nilotinib) compared to Glivec (imatinib) at achieving deeper molecular responses across various Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) patient populations, including newly diagnosed patients, patients with residual disease who switched to Tasigna after long-term treatment with Glivec, and patients who failed to respond to frontline Glivec (as defined by 2013 European LeukemiaNet [ELN] guidelines).
Ozone exposure, even at levels deemed safe by current clean air standards, can have a significant and negative effect on lung function, according to researchers at the University of California Davis.
A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
› Verified 8 days ago
Dr. Celia Lee Storey, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3939 Houma Blvd, Bldg. 6, Suite 224, Metairie, LA 70006 Phone: 504-454-2900 Fax: 504-454-2915 | |
Dr. Danielle Lynette Richard, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4200 Houma Blvd, Metairie, LA 70006 Phone: 504-503-4000 | |
Dr. Amanda Lynne Mudek, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2520 Harvard Ave Fl 1, Metairie, LA 70001 Phone: 504-708-4810 | |
Dr. Maria Markiewicz, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2520 Harvard Ave, Suite 2b, Metairie, LA 70001 Phone: 504-454-3004 Fax: 504-454-3004 | |
Joseph A. Delucca, Dpm, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 3101 Ridgelake Dr, Metairie, LA 70002 Phone: 504-831-2671 Fax: 504-831-2646 | |
Dr. Steven Joseph Zichichi, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3901 Houma Blvd, Suite 204, Metairie, LA 70006 Phone: 504-888-9403 Fax: 504-888-2895 | |
Dr. Marc Steven Glovinsky, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3939 Houma Blvd, Bldg. 6, Suite 224, Metairie, LA 70006 Phone: 504-454-2900 Fax: 504-454-2915 |